ResearchDuration and Timing of Adjuvant Tyrosine Kinase Inhibitor Therapy in Localized Renal Cell Carcinoma: A Multi-institutional Analysis From the ICICLE-Registry
ResearchPerioperative and anesthetic outcomes in patients undergoing nephrectomy for advanced kidney cancer
ResearchDeveloping biomarkers and methods of risk stratification: Consensus statements from the International Kidney Cancer Symposium North America 2024 Think Tank
ResearchTemporal Trends and Socioeconomic Determinants of Cytoreductive Nephrectomy Utilization for Metastatic Renal Cell Carcinoma in the USA
ResearchPatient, Physician, and Assessor Blinding in Phase III Randomized Trials in Oncology: A Meta-Epidemiological Analysis
ResearchMetastasis-directed radiotherapy without systemic therapy for oligometastatic clear-cell renal-cell carcinoma: primary efficacy analysis of a single-arm, single-centre, phase 2 trial
ResearchCase Report: Successful delivery following chemotherapy in a pregnant patient with metastatic SMARCB1-deficient renal medullary carcinoma
ResearchTreatment-Related Adverse Events and Associated Outcomes in Patients With Advanced Urothelial Carcinoma Treated With Enfortumab Vedotin: Analysis of the UNITE Study
ResearchEfficacy of erdafitinib before or after enfortumab vedotin in FGFR3-altered advanced urothelial cancer: analysis of the UNITE collaborative study
ResearchIdentification of therapeutic targets for renal medullary carcinoma via integrated genomic and transcriptomic profiling
ResearchEvaluating Clinical Tools to Monitor Cardiovascular Risk in Men With Prostate Cancer Receiving Hormone Therapy